Press Releases
IXICO's CEO Giulio Cerroni to present at Shares, Cenkos Growth & Innovation Forum
Our CEO, Giulio Cerroni will be presenting at next week's Growth & Innovation Forum, taking place at the Business Design Centre in London N1 on Tuesday 11th February. Giulio will be presenting in the Flower Room at 12. 15.
Read more
IXICO Supports the Alzheimer's Disease Neuroimaging Initiative
IXICO today announced funding support for the Alzheimer's Disease Neuroimaging Initiative (ADNI), and two of their scientists will join the ADNI-Private Partner Scientific Board (PPSB). ADNI is a longitudinal multicentre study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer's disease (AD).
Read more
Alison Howie, IXICO's Chief Product Officer to participate in AI tech panel at the 6th LSX World Congress
We are delighted to announce that our Chief Product Officer, Alison Howie will be participating in next week's LSX World Congress, taking place in London on 4-5 February. Alison will be participating in the keynote panel discussion entitled 'Realising AI’s potential in life sciences and healthcare' on Wednesday 5th February at 15.
Read more
IXICO to Present Tau PET Imaging Research at Human Amyloid Imaging Conference
IXICO today announces it has partnered with the Human Amyloid Imaging Conference (15-17 January 2020, Miami, USA) as a Bronze Sponsor and will be presenting scientific posters highlighting its latest methodology advances in Tau Positron Emission Tomography (PET) and Amyloid PET imaging to enhance clinical insights in Alzheimer’s therapeutic developments.
Read more
IXICO announces updates to client contracts
£2. 4 million expansion of study programmes with two large pharma client contracts IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, today announces: - £1. 8 million extension to a Phase III study in Huntington's Disease (HD), previously announced in September 2018 - £0.
Read more
IXICO Releases 2019 Annual Report and Notice of AGM
IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience, confirms that the Annual Report and Accounts for the year ended 30 September 2019 ("Annual Report and Accounts 2019") and the Notice of Annual General Meeting ("AGM") have been posted to shareholders on 12 December and 16 December, respectively.
Read more
IXICO Releases Financial Results for the year ended 30 September 2019
First profitable full year built upon increased penetration of growing market combined with operational leverage IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience, today announces its final results for the year ended 30 September 2019.
Read more
IXICO to Present Latest Research at Upcoming Clinical Trials on Alzheimer's Disease Congress
IXICO today announces that it is scheduled to attend and present scientific posters at the 2019 Clinical Trials on Alzheimer's Disease (CTAD) Congress held from 4th-7th December 2019 in San Diego, California, USA.
Read more1-8 of 11 results